BridgeMD
New treatment option for Acute Myocardial Infarction
Official title Arrhythmia Detection After MI
ClinicalTrials.gov ID: NCT05073419
What this study is testing
- What it's testing
- Patients post acute myocardial infarction (AMI) have a high risk of mortality but the use of an implantable defibrillator in the early aftermath of an AMI has not been shown to improve patients' survival. The VEST trial recently demonstrated an improved overall survival in post AMI patients with the use of a wearable defibrillator.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults, age 18 years or older
- AMI (STEMI and NSTEMI)
- Willing to give written informed consent
- Expected discharge from hospital within 7 days of AMI
- Willing to receive ICM insertion within 21 days of index AMI
You likely can't join if
- Existing pacemaker, ICD, ICM, or any other implantable cardiac electronic device
- Pregnant
- Index AMI was more than 21 days
- Unwilling/cannot insert ICM within 21 days post AMI
- Planned ICD implant, planned CABG or any open-heart surgery (e.g. for severe valvular disease)
The study team makes the final eligibility decision.
Where it's taking place
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.